what are the long term effects of glp-1 Long-term Success GLP-1s Hinges on More Than Just a Prescription Why do patients stop GLP-1

No coupons, no pre-approval battles, no surprise pharmacy bill

A Certificate of Analysis is a laboratory document containing analytical information specific to an individual production batch where available

Results Patients lose an average of 10-15% of body weight over 68 weeks in registration trials for FDA-approved formulations

In head-to-head trials, tirzepatide produced substantially greater weight loss than semaglutide at comparable doses

It activates one receptor (GLP-1) instead of two or three

The most frequently reported adverse effects are gastrointestinal in nature and typically occur during treatment initiation or dose escalation